Journal of Clinical Oncology · 2010 · 14 citations · 0 references
MedicinePharmacologyPharmacotherapyChemotherapyClinical PharmacologyOncology PharmacotherapyChemotherapy Toxicity ManagementDrug ToxicityToxicity Management5-Fluorouracil Therapy5-Fluorouracil TreatmentAntagonist ActivityEmergency Antidote UseInfusion Pump SystemsInfusion Pump TherapySupportive Antidotal CareSupportive Cancer Care
9084 Background: 5-fluorouracil (5-FU) is widely used to treat solid tumors and is often administered via infusion pump at or near its maximum tolerated dose. The common use of infusion pumps loaded with 5-FU for infusion over several days increases the possibility of potentially lethal overdoses due to pump malfunction or misprogramming. Uridine triacetate (vistonuridine) is an orally bioavailable prodrug of uridine, a direct biochemical antagonist of 5-FU toxicity. Uridine nucleotides derived from uridine triacetate dilute intracellular fluorouridine nucleotide anabolites of 5-FU, reducing their lethal incorporation into RNA. Successful outcomes for 17 5-FU overdose patients treated with uridine triacetate were reported at ASCO in 2009, along with 13 historical cases of comparable 5-FU overdoses treated with supportive care only. Consequent increased awareness of uridine triacetate as an antidote has resulted in a significant increase in the frequency of requests for emergency use of uridine triacetate. Methods: Uridine triacetate was provided under emergency IND provisions when requested by clinical sites following 5FU overdoses, most due to infusion pumps delivering 5FU faster than intended. Patients received uridine triacetate (10g q6h for 20 doses) beginning as soon as possible after overdose. Patient outcomes were monitored and compared to historical reports of 5-FU overdoses where uridine triacetate was not used. Results: More than 28 patients overdosed with 5-FU have now been treated with uridine triacetate as an antidote. All patients treated to date recovered fully, including an extreme case with a 5-FU dose 10-fold higher than intended (10,000 mg versus 1,000 mg, in 1 hour). Strong reductions in anticipated GI and hematologic toxicities were observed. A total of 43 historical cases of 5-FU overdoses not treated with uridine triacetate (39 fatal) have been identified, highlighting the potentially severe consequences of 5-FU overdoses and the need for an effective antidote. Conclusions: Uridine triacetate appears to be a safe and effective, life-saving antidote to 5-FU overdose. Author Disclosure Employment or Leadership Position Consultant or Advisory Role Stock Ownership Honoraria Research Funding Expert Testimony Other Remuneration Wellstat Therapeutics Corporation